Cardiovascular session icon

Emerging role of NLRP3 inflammasome as a therapeutic target in cardiovascular and infectious diseases

  • Chair(s):

    Na Li,
    Associate Professor, Department of Medicine, Baylor College of Medicine, Houston, TX, The United States of America

  • Session description:

    Targeting the NLRP3 inflammasome for the treatment of inflammatory diseases
    Dr Rebecca Coll
    Lecturer in Immunobiology, Queen’s University Belfast, Belfast, United Kingdom

    CaMKII signaling and NLRP3 inflammasome activation in cardiomyocyte mediated inflammation
    Professor Joan Heller Brown
    Professor and Chair of the Department of Pharmacology, UC San Diego, School of Medicine, United States of America

    Oral communication speaker - to be confirmed in 2023.

    Pathological role of NLRP3 inflammasome in the development of atrial fibrillation
    Dr Marcel Tekook
    Department of Pharmacology, University of Duisburg – Essen Germany, Essen, Germany

    Inflammasome activation and COVID-19 patients
    Stefano Toldo Associate Professor of Medicine, Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, School of Medicine, Molecular Research Building 5 (MR5), Charlottesville, VA, America


03 Jul 2023


4:05 pm - 6:30 pm


Go to Top